Your browser doesn't support javascript.
loading
The added value of 18-fluorodeoxyglucose-positron emission tomography in the diagnosis of the behavioral variant of frontotemporal dementia.
Kerklaan, B J; van Berckel, B N M; Herholz, K; Dols, A; van der Flier, W M; Scheltens, P; Pijnenburg, Y A L.
Afiliação
  • Kerklaan BJ; Alzheimer Center VU Medical Center, Amsterdam, The Netherlands Department of Neurology, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands Department of Neurology, Zaans Medical Center, Zaandam, The Netherlands bj.kerklaan@slaz.nl.
  • van Berckel BN; Department of Nuclear Medicine, VU Medical Center, Amsterdam, The Netherlands.
  • Herholz K; Wolfson Molecular Imaging Center, University of Manchester, Manchester, United Kingdom.
  • Dols A; GGZ in Geest/Alzheimer Center VU Medical Center, Amsterdam, The Netherlands.
  • van der Flier WM; Alzheimer Center VU Medical Center, Amsterdam, The Netherlands.
  • Scheltens P; Alzheimer Center VU Medical Center, Amsterdam, The Netherlands.
  • Pijnenburg YA; Alzheimer Center VU Medical Center, Amsterdam, The Netherlands.
Am J Alzheimers Dis Other Demen ; 29(7): 607-13, 2014 Nov.
Article em En | MEDLINE | ID: mdl-24576796
UNLABELLED: Characteristic frontotemporal abnormalities on structural or functional neuroimaging are mandatory for a diagnosis of probable behavioral variant of frontotemporal dementia (bvFTD) according to the new criteria. 18-Fluorodeoxyglucose-positron emission tomography (18F-FDG-PET) imaging is commonly reserved for patients with suspected bvFTD without characteristic structural neuroimaging results. We studied the diagnostic value of 18F-FDG-PET in these patients. METHODS: The 18F-FDG-PET was performed in 52 patients with suspected bvFTD but lacking characteristic structural neuroimaging results. The clinical diagnosis of bvFTD in the presence of functional decline (bvFTD/fd+) after a follow-up period of 2 years was used as a golden standard. RESULTS: The sensitivity of 18F-FDG-PET for bvFTD/fd+ was 47% at a specificity of 92%. The differential diagnosis comprised alternative neurodegenerative and psychiatric disorders and a benign phenocopy of bvFTD. CONCLUSIONS: The 18F-FDG-PET is able to identify nearly half of the patients with bvFTD who remain undetected by magnetic resonance imaging. In our selected group, high specificity enables exclusion of psychiatric and other neurodegenerative disorders.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Radiofarmacêuticos / Fluordesoxiglucose F18 / Tomografia por Emissão de Pósitrons / Demência Frontotemporal Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Am J Alzheimers Dis Other Demen Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Radiofarmacêuticos / Fluordesoxiglucose F18 / Tomografia por Emissão de Pósitrons / Demência Frontotemporal Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Am J Alzheimers Dis Other Demen Ano de publicação: 2014 Tipo de documento: Article